Search Login Register

Acute Myelomonocytic Leukemia Summary

Description: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.

Also Known As: Leukemia, Myelomonocytic, Acute; Acute Myelomonocytic Leukemias; Leukemia, Acute Myelomonocytic; Leukemia, Naegeli-Type Myeloid; Leukemias, Acute Myelomonocytic Show All >>

Networked: 191 relevant articles (10 outcomes, 11 trials/studies) for this Disease

Key Drugs and Agents for Acute Myelomonocytic Leukemia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cytarabine (Cytosar-U) : 3 outcomes in 10 results : FDA 13 Generic
  2. Thioguanine (Tioguanine) : 2 outcomes in 4 results : FDA 1
  3. Vincristine (Oncovin) : 2 outcomes in 3 results : FDA 17 Generic
  4. Melphalan (Alkeran) : 1 outcome in 5 results : FDA 2 Generic
  5. Acute erythroleukemia : 1 outcome in 4 results : IBA
  6. Daunorubicin (Cerubidine) : 1 outcome in 3 results : FDA 8 Generic
  7. Doxorubicin (Adriamycin) : 1 outcome in 2 results : FDA 12 Generic
  8. gemtuzumab (gemtuzumab ozogamicin) : 1 outcome in 1 result : FDA 1
  9. dimemorfan (AT 17) : 1 outcome in 1 result : IBA
  10. Etoposide (VP 16) : 1 study in 10 results : FDA 16 Generic
Show All >>

Diseases Related to Acute Myelomonocytic Leukemia

  1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
  2. Leukemia
  3. Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
  4. Scleromyxedema (Lichen Myxedematosus)
  5. Pneumonia (Pneumonitis)
Show All >>

Key Therapies for Acute Myelomonocytic Leukemia

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 3 outcomes in 34 results
  2. Catheters : 1 outcome in 2 results
  3. Hematopoietic Stem Cell Transplantation : 1 outcome in 2 results
  4. Homologous Transplantation (Allograft) : 1 outcome in 1 result
  5. Aftercare (After-Treatment) : 6 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.